Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts

被引:0
|
作者
Ting Zeng
Yaoqin Lu
Yanji Zhao
Zihao Guo
Shengzhi Sun
Zhidong Teng
Maozai Tian
Jun Wang
Shulin Li
Xucheng Fan
Weiming Wang
Yongli Cai
Gengze Liao
Xiao Liang
Daihai He
Kai Wang
Shi Zhao
机构
[1] Xinjiang Medical University,School of Public Health
[2] Urumqi Center for Disease Control and Prevention,Department of Applied Mathematics
[3] Hong Kong Polytechnic University,JC School of Public Health and Primary Care
[4] Chinese University of Hong Kong,School of Public Health
[5] Capital Medical University,Department of Medical Engineering and Technology
[6] Xinjiang Medical University,School of Mathematics and Statistics
[7] Huaiyin Normal University,Department of Rehabilitation Sciences
[8] Hong Kong Polytechnic University,Research Institute for Future Food
[9] Hong Kong Polytechnic University,Centre for Health Systems and Policy Research
[10] Chinese University of Hong Kong,undefined
来源
关键词
COVID-19; Omicron variant; Vaccine effectiveness; Asymptomatic infection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates
    Pal, Ranajit
    Ferrari, Maria Grazia
    Honda-Okubo, Yoshikazu
    Wattay, Lauren
    Caple, Jesica
    Navarrete, Jennifer
    Andersen, Hanne
    Petrovsky, Nikolai
    [J]. VACCINE, 2024, 42 (05) : 1122 - 1135
  • [42] Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
    Intawong, Kannikar
    Chariyalertsak, Suwat
    Chalom, Kittipan
    Wonghirundecha, Thanachol
    Kowatcharakul, Woravut
    Thongprachum, Aksara
    Chotirosniramit, Narain
    Noppakun, Kajohnsak
    Khwanngern, Krit
    Teacharak, Worachet
    Piamanant, Prapon
    Khammawan, Pimpinan
    Iamsirithaworng, Sopon
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (06) : 1178 - 1186
  • [43] Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
    Ciesla, Allison Avrich
    Wiegand, Ryan E.
    Smith, Zachary R.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Miller, Joseph
    Accorsi, Emma K.
    Verani, Jennifer R.
    Shang, Nong
    Derado, Gordana
    Pilishvili, Tamara
    Link-Gelles, Ruth
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (05):
  • [44] Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
    Di Fusco, Manuela
    Marczell, Kinga
    Thoburn, Elizabeth
    Wiemken, Timothy. L. L.
    Yang, Jingyan
    Yarnoff, Benjamin
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 509 - 524
  • [45] Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
    Kodera, Sachiko
    Niimi, Yuki
    Rashed, Essam A.
    Yoshinaga, Naoki
    Toyoda, Masashi
    Hirata, Akimasa
    [J]. VACCINES, 2022, 10 (11)
  • [46] Real-World Effectiveness of Primary Series and Booster Doses of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2 Variant Infection in China: A Retrospective Cohort Study
    Tang, Lin
    Wang, Fu-Zhen
    Rodewald, Lance E.
    Wang, Xuan-Yi
    Liu, Si-Yu
    Liu, Qian-Qian
    Wang, Xiao-Qi
    Wu, Dan
    Li, Ming-Shuang
    Zhang, Qian
    Shao, Yi-Ming
    Huang, Li-Fang
    Song, Yu-Dan
    Huang, Yong
    Zeng, Xiang
    Liu, Li-Jun
    Yang, Hong
    Huang, Ao-Di
    Bao, Li-Ming
    Zheng, Hui
    Ma, Chao
    Lv, Xiao-Ya
    Song, Lei
    Ma, Zhao
    Wang, Shu-Guang
    Ma, Hao
    Guan, Wei-Jie
    Wu, Zhi-Yin
    Zhong, Nan-Shan
    Yin, Zun-Dong
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (03): : 261 - 269
  • [47] Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily
    Vella, Giuseppe
    Genovese, Dario
    Belluzzo, Miriam
    Mazzeo, Luca
    Pisciotta, Vincenzo
    Amodio, Emanuele
    [J]. HEALTHCARE, 2023, 11 (03)
  • [48] Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants
    Maltezou, Helena C.
    Gamaletsou, Maria N.
    Giannouchos, Theodoros, V
    Koukou, Dimitra-Maria
    Sourri, Flora
    Karapanou, Amalia
    Lemonakis, Nikolaos
    Souliotis, Kyriakos
    Lourida, Athanasia
    Panagopoulos, Periklis
    Hatzigeorgiou, Dimitrios
    Sipsas, Nikolaos, V
    [J]. VACCINE, 2024, 42 (17) : 3693 - 3698
  • [49] Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes (vol 14, 1273 , 2023)
    Grewal, Ramandip
    Nguyen, Lena
    Buchan, Sarah A.
    Wilson, Sarah E.
    Nasreen, Sharifa
    Austin, Peter C.
    Brown, Kevin A.
    Fell, Deshayne B.
    Gubbay, Jonathan B.
    Schwartz, Kevin L.
    Tadrous, Mina
    Wilson, Kumanan
    Kwong, Jeffrey C.
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [50] Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5
    Molina, Kyle C.
    Kennerley, Victoria
    Beaty, Laurel E.
    Bennett, Tellen D.
    Carlson, Nichole E.
    Mayer, David A.
    Peers, Jennifer L.
    Russell, Seth
    Wynia, Matthew K.
    Aggarwal, Neil R.
    Ginde, Adit A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 132 : 34 - 39